Penn’s royalties from Pfizer-BioNTech COVID-19 vaccine grow to at least $2 billion after new settlement
The Nobel Prize-winning scientific innovation underlying the COVID-19 vaccine proved to be a notable financial boon for the ...
BioNTech enters settlement with US agency, UPenn over COVID vaccine royalties
BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University ...
Hosted on MSN22d
BioNTech Stock In Focus After $791.5M Settlement With NIH: Retail Cautious
S hares of BioNTech slipped 0.83% in after-hours trading on Friday after the company said it would pay $791.5 million in a settlement payment with the National Institutes of Health, drawing a ...
Yahoo Finance24d
BioNTech to pay $791.5M in settlement agreement with the NIH
In a regulatory filing, BioNTech (BNTX) said ... On December 20, 2024, the Company entered into a settlement agreement with the NIH. Under the terms of the Settlement Agreement, the Company ...
Yahoo Finance24d
BioNTech to pay $467M in settlement agreement with University of Pennsylvania
Upon partial receipt of the Settlement Payment, Penn has agreed to dismiss with prejudice the litigation Penn filed against the Company and its former subsidiary, BioNTech RNA Pharmaceuticals ...
Seeking Alpha24d
BioNTech inks $1B settlements with NIH and Penn to resolve COVID vaccine royalty claims
Concurrently, BioNTech (BNTX) announced a settlement agreement worth $467M with Penn to resolve a lawsuit filed by the university over royalty claims related to the COVID-19 shot. The deal ...
The Business Journals22d
Penn to receive $467M under settlement with BioNTech over Covid-19 vaccine royalties
In addition to its deal with Penn, BioNTech also reached a $791.5 million settlement to resolve a dispute under which the U.S. government said it was owed in royalty payments from the licensing ...